Correlation of adenomyosis features to live birth rates after the first IVF/ICSI treatment, when using the revised Morphological Uterus Sonographic Assessment group definitions.

ICSI IVF adenomyosis artificial intelligence assisted reproductive treatment live birth rate ultrasound

Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
09 Oct 2024
Historique:
revised: 21 08 2024
received: 07 03 2024
accepted: 25 09 2024
medline: 9 10 2024
pubmed: 9 10 2024
entrez: 9 10 2024
Statut: aheadofprint

Résumé

Data regarding the impact of adenomyosis on the outcomes after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment are conflicting. Standardized diagnostic criteria are prerequisites for studying a potential association between adenomyosis and IVF/ICSI treatment outcomes. This study aims to examine the cumulative live birth rate (CLBR) after the first IVF/ICSI treatment in women with or without direct or indirect features of adenomyosis, using the revised Morphological Uterus Sonographic Assessment (MUSA) group definitions. This was a prospective cohort study of 1037 women aged 25-≤39 years, undergoing their first IVF/ICSI treatment between January 2019 and October 2022. The presence of MUSA features of adenomyosis was assessed prior to treatment start. The CLBR after the first IVF/ICSI treatment was 424/1037 (40.9%, 95% CI, 37.9-43.8) in the total cohort. Women with direct features of adenomyosis had lower CLBR, 25/102 (24.5%; 95% CI, 17.5-31.5) than women without, 399/935 (42.7%; 95% CI, 39.5-45.8), p < 0.001. The adjusted relative risk (aRR) for live birth for women with direct features of adenomyosis compared to women without was 0.62 (95% CI, 0.43-0.88), p = 0.007. Direct features were associated with a higher risk of miscarriage after frozen embryo transfer, aRR 2.88 (95% CI, 1.49-5.57), p = 0.002. Women with indirect features had a lower CLBR [50/188 (26.6%, 95% CI, 20.3-32.9)] than women without [399/935, (42.7%, 95% CI, 39.5-45.8)], aRR 0.58 (95% CI, 0.45-0.75), p < 0.001. For features located in the inner myometrium, the aRR for live birth was 0.29 (95% CI 0.11-0.74), p = 0.010 and for the outer myometrium 2.61 (95% CI 1.42-4.8), p = 0.002. An interrupted junctional zone was the single feature that impacted CLBR the most. The presence of direct or indirect MUSA features of adenomyosis correlates to reduced live birth rates in women undergoing their first IVF/ICSI treatment. Features located in the inner myometrium, particularly an interrupted junctional zone, reduced the chance of live birth the most, whereas location in the outer myometrium was associated with higher chances of live birth. Systematic ultrasound examinations should be considered for women scheduled for IVF/ICSI treatment, for adequate counseling on the chances of successful treatment.

Identifiants

pubmed: 39382305
doi: 10.1111/aogs.14986
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Region Skåne

Informations de copyright

© 2024 The Author(s). Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Références

Bird CC, McElin TW, Manalo‐Estrella P. The elusive adenomyosis of the uterus—revisited. Am J Obstet Gynecol. 1972;112:583‐593.
Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta‐analysis. Hum Reprod. 2014;29:964‐977.
Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta‐analysis. Hum Reprod Update. 2019;25:592‐632.
Mavrelos D, Holland TK, O'Donovan O, et al. The impact of adenomyosis on the outcome of IVF‐embryo transfer. Reprod Biomed Online. 2017;35:549‐554.
Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update. 2012;18:374‐392.
Higgins C, Fernandes H, Da Silva Costa F, Martins WP, Vollenhoven B, Healey M. The impact of adenomyosis on IVF outcomes: a prospective cohort study. Hum Reprod Open. 2021;2021:hoab015.
Costello MF, Lindsay K, McNally G. The effect of adenomyosis on in vitro fertilisation and intra‐cytoplasmic sperm injection treatment outcome. Eur J Obstet Gynecol Reprod Biol. 2011;158:229‐234.
Wang XL, Xu ZW, Huang YY, Lin S, Lyu GR. Different subtypes of ultrasound‐diagnosed adenomyosis and in vitro fertilization outcomes: a systematic review and meta‐analysis. Acta Obstet Gynecol Scand. 2023;102:657‐668.
Tomassetti C, Meuleman C, Timmerman D, D'Hooghe T. Adenomyosis and subfertility: evidence of association and causation. Semin Reprod Med. 2013;31:101‐108.
Mishra I, Melo P, Easter C, Sephton V, Dhillon‐Smith R, Coomarasamy A. Prevalence of adenomyosis in women with subfertility: systematic review and meta‐analysis. Ultrasound Obstet Gynecol. 2023;62:23‐41.
Harmsen MJ, Van den Bosch T, de Leeuw RA, et al. Consensus on revised definitions of morphological uterus sonographic assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol. 2022;60:118‐131.
Van den Bosch T, Dueholm M, Leone FP, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46:284‐298.
Van den Bosch T, de Bruijn AM, de Leeuw RA, et al. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019;53:576‐582.
Alson S, Jokubkiene L, Henic E, Sladkevicius P. Prevalence of endometrioma and deep infiltrating endometriosis with transvaginal ultrasonographic examination of women with subfertility undergoing assisted reproductive treatment: a prospective cohort study. Fertil Steril. 2022;118:915‐923.
Alson S, Jokubkiene L, Henic E, Sladkevicius P. Prevalence of adenomyosis features in women scheduled for assisted reproductive treatment, using the Morphological Uterus Sonographic assessment group definitions. Acta Obstet Gynecol Scand. 2024;103:1142‐1152.
Alson S, Henic E, Jokubkiene L, Sladkevicius P. Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first IVF/ICSI treatment. Fertil Steril. 2024;121:832‐841.
Van Holsbeke C, Van Calster B, Guerriero S, et al. Endometriomas: their ultrasound characteristics. Ultrasound Obstet Gynecol. 2010;35:730‐740.
Guerriero S, Condous G, van den Bosch T, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol. 2016;48:318‐332.
Liu S, Xie Y, Li F, Jin L. Effectiveness of ultra‐long protocol on in vitro fertilization/intracytoplasmic sperm injection‐embryo transfer outcome in infertile women with endometriosis: a systematic review and meta‐analysis of randomized controlled trials. J Obstet Gynaecol Res. 2021;47:1232‐1242.
Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11:307‐311.
Thalluri V, Tremellen KP. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment. Hum Reprod. 2012;27:3487‐3492.
Naftalin J, Hoo W, Pateman K, Mavrelos D, Holland T, Jurkovic D. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012;27:3432‐3439.
Cozzolino M, Tartaglia S, Pellegrini L, Troiano G, Rizzo G, Petraglia F. The effect of uterine Adenomyosis on IVF outcomes: a systematic review and meta‐analysis. Reprod Sci. 2022;29:3177‐3193.
Cozzolino M, Cosentino M, Loiudice L, et al. Impact of adenomyosis on in vitro fertilization outcomes in women undergoing donor oocyte transfers: a prospective observational study. Fertil Steril. 2023;121:480‐488.
Wang Y, Yi YC, Guu HF, et al. Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin‐releasing hormone agonist treatment and frozen embryo transfer. Sci Rep. 2023;13:6741.
Bulun SE, Yildiz S, Adli M, et al. Endometriosis and adenomyosis: shared pathophysiology. Fertil Steril. 2023;119:746‐750.
Brosens I, Derwig I, Brosens J, Fusi L, Benagiano G, Pijnenborg R. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod. 2010;25:569‐574.
Wang S, Duan H. The role of the junctional zone in the management of adenomyosis with infertility. Front Endocrinol (Lausanne). 2023;14:1246819.
Barbanti C, Centini G, Lazzeri L, et al. Adenomyosis and infertility: the role of the junctional zone. Gynecol Endocrinol. 2021;1‐7:577‐583.
Naftalin J, Hoo W, Nunes N, Holland T, Mavrelos D, Jurkovic D. Association between ultrasound features of adenomyosis and severity of menstrual pain. Ultrasound Obstet Gynecol. 2016;47:779‐783.
Exacoustos C, Luciano D, Corbett B, et al. The uterine junctional zone: a 3‐dimensional ultrasound study of patients with endometriosis. Am J Obstet Gynecol. 2013;209(248):e1‐e7.
Sanchez AM, Vanni VS, Bartiromo L, et al. Is the oocyte quality affected by endometriosis? A review of the literature. J Ovarian Res. 2017;10:43.
Diaz I, Navarro J, Blasco L, Simon C, Pellicer A, Remohi J. Impact of stage III‐IV endometriosis on recipients of sibling oocytes: matched case‐control study. Fertil Steril. 2000;74:31‐34.
Dason ES, Maxim M, Hartman A, et al. Pregnancy outcomes with donor oocyte embryos in patients diagnosed with adenomyosis using the morphological uterus sonographic assessment criteria. Fertil Steril. 2023;119:484‐489.
Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol (Lausanne). 2018;9:327.

Auteurs

Sara Alson (S)

Department of Clinical Sciences, Obstetric, Gynecological and Prenatal Ultrasound Research, Lund University, Malmö, Sweden.
Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Sweden.
Reproductive Medicine Center, Skåne University Hospital, Malmö, Sweden.

Emir Henic (E)

Reproductive Medicine Center, Skåne University Hospital, Malmö, Sweden.
Department of Translational Medicine, Lund University, Malmö, Sweden.

Stefan R Hansson (SR)

Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Sweden.
Department of Clinical Sciences, Unit for Translational Obstetric Research, Lund University, Sweden.

Povilas Sladkevicius (P)

Department of Clinical Sciences, Obstetric, Gynecological and Prenatal Ultrasound Research, Lund University, Malmö, Sweden.
Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Sweden.

Classifications MeSH